Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 HKD | -4.64% | +18.52% | -56.63% |
Jun. 05 | ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment | MT |
Jun. 05 | Alphamab Strikes Deal with Nasdaq-Listed ArriVent to Co-Develop Antibody Drug Conjugates | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.63% | 373M | |
+55.70% | 59.34B | |
+42.95% | 40.24B | |
-5.26% | 39.88B | |
-5.56% | 28.55B | |
+16.34% | 27.26B | |
-21.05% | 19.23B | |
+32.26% | 12.61B | |
+3.45% | 12.49B | |
+26.29% | 12.28B |
- Stock Market
- Equities
- 9966 Stock
- News Alphamab Oncology
- Alphamab Oncology : Nomura Adjusts Alphamab Oncology's Price Target to HK$25.1 From HK$17.2, Keeps at Buy